-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Day One Biopharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q2 2023 to Q3 2024.
- Day One Biopharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$882K.
- Day One Biopharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was $7.14M.
- Day One Biopharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)